The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Xenon Pharmaceuticals Inc shares valued at $647,306 were sold by MORTIMER IAN on Dec 05 ’25. At $45.03 per share, MORTIMER IAN sold 14,375 shares. The insider’s holdings dropped to 16,830 shares worth approximately $0.73 million following the completion of this transaction.
Also, MORTIMER IAN sold 10,830 shares, netting a total of over 495,207 in proceeds. Following the sale of shares at $45.73 each, the insider now holds 6,000 shares.
Before that, IAN MORTIMER had added 10,830 shares to its account. In a trade valued at $495,248, the Officer bought Xenon Pharmaceuticals Inc shares for $45.73 each.
Analysts at Chardan Capital Markets started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of February 11, 2025, Deutsche Bank has initiated its “Buy” rating for XENE.
Analyzing XENE Stock Performance
On last trading session, Xenon Pharmaceuticals Inc [NASDAQ: XENE] plunged -0.18% to $43.44. The stock’s lowest price that day was $43.04, but it reached a high of $43.86 in the same session. During the last five days, there has been a drop of approximately -1.92%. Over the course of the year, Xenon Pharmaceuticals Inc shares have jumped approximately 1.69%. Shares of the company reached a 52-week high of $46.60 on 12/08/25 and a 52-week low of $26.74 on 04/09/25.
Support And Resistance Levels for Xenon Pharmaceuticals Inc (XENE)
According to the 24-hour chart, there is a support level at 43.03, which, if violated, would cause prices to drop to 42.61. In the upper region, resistance lies at 43.87. The next price resistance is at 44.29. RSI (Relative Strength Index) is 55.93 on the 14-day chart, showing neutral technical sentiment.
Is Xenon Pharmaceuticals Inc subject to short interest?
Stocks of Xenon Pharmaceuticals Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.1 million shares to 5.89 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 5.79 million shares. A jump of 1.76% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.31 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.31.
Which companies own the most shares of Xenon Pharmaceuticals Inc (XENE)?
In terms of Xenon Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 26.38% from the previous closing price of $43.52. Analysts anticipate Xenon Pharmaceuticals Inc stock to reach 58 by 2025, with the lowest price target being 44. In spite of this, 10 analysts ranked Xenon Pharmaceuticals Inc stock as Buy at the end of 2025. On October 01, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $53.
